We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFBD icon
13376
Infobird
IFBD
$8.68M
$28K ﹤0.01%
7
-5
-42% -$35.5K
PLX icon
13377
CALL
Protalix BioTherapeutics
PLX
$179M
$28K ﹤0.01%
33,100
-74,700
-69% -$78.2K
SINT icon
13378
SiNtx Technologies
SINT
$10.4M
$28K ﹤0.01%
+2
New +$40.1K
TALK icon
13379
PUT
Talkspace
TALK
$871M
$28K ﹤0.01%
14,000
-2,900
-17% -$8.3K
CSCI
13380
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$28K ﹤0.01%
782
-411
-34% -$21.6K
PHLT
13381
PUT
DELISTED
Performant Healthcare Inc
PHLT
$28K ﹤0.01%
11,600
-30,700
-73% -$91.4K
ROI
13382
DELISTED
RiskOn International, Inc. Common Stock
ROI
$28K ﹤0.01%
+421
New +$44.7K
LOCL.WS
13383
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
$28K ﹤0.01%
+42,722
New +$37.7K
APTO
13384
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$28K ﹤0.01%
46
-28
-38% -$26.3K
AVX
13385
Avax One Technology Ltd
AVX
$23.5M
0
FTK icon
13386
PUT
Flotek Industries
FTK
$1.3B
$27K ﹤0.01%
+4,033
New +$22.9K
GTE icon
13387
PUT
Gran Tierra Energy
GTE
$325M
$27K ﹤0.01%
3,510
-13,550
-79% -$110K
SLNO
13388
PUT
DELISTED
Soleno Therapeutics
SLNO
$27K ﹤0.01%
4,420
-1,600
-27% -$16.8K
SURG icon
13389
SurgePays
SURG
$7.08M
$27K ﹤0.01%
+13,584
New +$34.8K
SYBX
13390
DELISTED
Synlogic
SYBX
$27K ﹤0.01%
753
-49
-6% -$1.9K
TRIB
13391
CALL
Trinity Biotech
TRIB
$7.88M
$27K ﹤0.01%
127
-13
-9% -$3.69K
TRIB
13392
Trinity Biotech
TRIB
$7.88M
$27K ﹤0.01%
126
+8
+7% +$2.27K
SLACW
13393
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$27K ﹤0.01%
32,163
-11,433
-26% -$9.79K
SIOX
13394
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$27K ﹤0.01%
21,300
+6,100
+40% +$10.8K
IVC
13395
PUT
DELISTED
Invacare Corporation
IVC
$27K ﹤0.01%
10,000
-36,800
-79% -$136K
HIL
13396
PUT
DELISTED
Hill International, Inc. Common Stock
HIL
$27K ﹤0.01%
13,800
+2,100
+18% +$4.33K
PSAGW
13397
DELISTED
Property Solutions Acquisition Corporation II Warrant
PSAGW
$27K ﹤0.01%
48,111
-737
-2% -$541
KLDO
13398
PUT
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$27K ﹤0.01%
11,400
-1,300
-10% -$5.29K
CHNR icon
13399
China Natural Resources
CHNR
$5.24M
$26K ﹤0.01%
1,128
+361
+47% +$14.9K
IMNN icon
13400
CALL
Imunon
IMNN
$6.93M
$26K ﹤0.01%
249
+154
+162% +$24K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.